Eye conditions provide new lens screening for Alzheimer's disease
Alzheimer's disease is difficult to diagnose as well as treat, but researchers now have a promising new screening tool using the window to the brain: the eye.
Aug 8, 2018
0
148
Alzheimer's disease is difficult to diagnose as well as treat, but researchers now have a promising new screening tool using the window to the brain: the eye.
Aug 8, 2018
0
148
Researchers at Joslin Diabetes Center have shown that a protein found in the eye can protect against and potentially treat diabetic eye disease. At high enough levels, Retinol Binding Protein 3 (or RBP3) prevents the development ...
Jul 3, 2019
0
1
Mother Nature could have the answer to treating several causes of blindness, according to a ground-breaking study involving scientists from the University of Surrey and the Eugene and Marilyn Glick Eye Institute at Indiana ...
Apr 9, 2019
0
182
(HealthDay)—Most Americans over 40 don't know the signs of diabetic retinopathy, a new survey finds.
Nov 2, 2020
0
9
Reporting on their study with lab-grown human cells, researchers at The Johns Hopkins University and the University of Maryland say that blocking a second blood vessel growth protein, along with one that is already well-known, ...
May 25, 2015
0
171
Diabetic retinopathy is considered one of the most disabling complications of diabetes and the leading cause of new cases of vision loss among adults.
Apr 6, 2018
0
398
Ranibizumab, a prescription drug commonly used to treat age-related vision loss, also reverses vision loss caused by diabetes among Hispanic and non-Hispanic whites, according to a new study led by investigators from the ...
Feb 18, 2015
0
25
In Mexico, at least 14 million people have developed macular edema due to diabetes (DME), which like retinopathy affects central vision and can lead to blindness if not treated early .
May 13, 2014
0
2
Ophthalmologists expect to see a few patients who might have injured to their eyes by staring at the sun during Monday's solar eclipse.
Aug 24, 2017
0
1
A team of engineers and scientists at the University of British Columbia has developed a device that can be implanted behind the eye for controlled and on-demand release of drugs to treat retinal damage caused by diabetes.
Jun 30, 2011
0
0